Association between IL-6-174G/C polymorphism and risk of multiple sclerosis: a meta-analysis

Genet Test Mol Biomarkers. 2014 Feb;18(2):127-30. doi: 10.1089/gtmb.2013.0387. Epub 2013 Dec 11.

Abstract

Objective: Interleukin-6 (IL-6) is a pleiotropic cytokine and important mediator of many inflammatory processes, which might affect susceptibility to multiple sclerosis (MS). The aim of this study was to assess the effect of IL-6-174G/C polymorphism on the risk of MS using a meta-analysis.

Materials and methods: The Pubmed, ISI Web of Science, Wanfang, VIP, and China National Knowledge Infrastructure databases were screened and six studies were included in the meta-analysis. Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CI) were calculated to evaluate the association between the IL-6-174G/C polymorphism and risk of MS.

Results: No significant association between the IL-6-174G/C polymorphism and risk of MS was observed in overall analyses. With stratification according to ethnicity, we found that carriers with the IL-6-174CC genotype had a 1.87-fold increased risk for the development of MS in Asians (recessive model: OR=1.87, 95% CI, 1.08-3.24), but not in Caucasians.

Conclusion: This meta-analysis provides evidence that the IL-6-174G/C polymorphism may be a risk factor for the development of MS in Asians. Further association studies with a larger sample size are required to confirm the result in different populations.

Publication types

  • Meta-Analysis
  • Review

MeSH terms

  • Case-Control Studies
  • Ethnicity / genetics
  • Genetic Association Studies
  • Genetic Predisposition to Disease
  • Genotype
  • Humans
  • Interleukin-6 / genetics*
  • Multiple Sclerosis / genetics*
  • Polymorphism, Single Nucleotide*
  • Risk Factors

Substances

  • IL6 protein, human
  • Interleukin-6